Form Health vs Mochi Health comparison
Form Health and Mochi Health both offer online GLP-1 care, but they differ sharply on clinical structure, insurance billing, and whether medications are FDA-approved or compounded.
The Patient-Level Decision Is Now a Sourcing Decision Too
- Form Health uses a physician-led, insurance-integrated model with a multidisciplinary team including dietitians and therapists; Mochi Health offers a lower-cost $99/month membership with licensed clinicians and less published detail about care intensity
- Both programs prescribe GLP-1 medications, but differ significantly in how much clinical oversight, dietary guidance, and behavioral support they provide alongside the prescription
- Neither program has published peer-reviewed outcomes data, so quality assessments rely on program structure, prescriber credentials, and user-reported experience rather than clinical trial results
1Overview
Both platforms connect patients with obesity medicine care and GLP-1 medications online. They differ in clinical structure, cost, and who they're built for. Here's what's confirmed about each, where the meaningful differences lie, and what to ask before you sign up.
2Medications available
Form Health
Form Health prescribes FDA-approved GLP-1 and GLP-1/GIP receptor agonist medications, including brand-name semaglutide and tirzepatide products, as part of individualized treatment plans.
Mochi Health
Mochi Health prescribes both brand-name and compounded versions of semaglutide and tirzepatide through partner compounding pharmacies. This is a material distinction that patients should understand before enrolling.
A note on compounded GLP-1 medications
The FDA has raised concerns about unapproved compounded GLP-1 drugs, citing risks related to quality control, improper storage, dosing errors, and fraudulent products. Compounded medications have not undergone the same FDA review for safety, efficacy, and manufacturing quality as brand-name drugs. The regulatory picture shifted in May 2025, when the FDA declared the semaglutide shortage resolved. Under FDA rules, compounding pharmacies are generally permitted to produce copies of a drug only while an official shortage is in effect. With the semaglutide shortage designation lifted, the legal basis for most compounded semaglutide has narrowed significantly. Patients currently using or considering compounded semaglutide through any platform should ask their prescriber directly how this affects their prescription. Tirzepatide's shortage status is separate and should be confirmed with the prescribing platform. Before enrolling in any telehealth weight-loss program, ask: Are the medications you prescribe brand-name and FDA-approved, or compounded? If compounded, what is the current regulatory basis for prescribing them?
3Cost and insurance
Form Health
Form Health accepts national health insurance plans, including Medicare. Out-of-pocket costs depend on a patient's individual plan, deductible, and coverage tier. Insurance acceptance does not guarantee coverage. GLP-1 medications frequently require prior authorization, and approval rates vary by insurer, plan type, and documented medical need. The cost of the medication itself, separate from program fees, can vary significantly depending on the drug, insurance tier, and pharmacy.
Mochi Health
Mochi Health charges $99 per month for program membership. Medication is billed separately through partner pharmacies; compounded versions are typically less expensive than brand-name drugs, though prices vary. The platform does not accept insurance for the membership fee but provides superbills for patients who want to seek reimbursement from their insurer.
What neither platform publishes clearly
Real-world insurance reimbursement success rates are not documented for either program, and drug costs are not always transparent upfront. Patients should request a complete breakdown of expected costs, including program fees, visit fees, and medication costs, before committing.
4Clinical monitoring and care intensity
Form Health
Form Health's model includes regular video visits with clinicians, ongoing messaging access between appointments, progress tracking through its app, and a multidisciplinary team that includes a physician, dietitian, and behavioral health support. This structure reflects OMA guidelines for comprehensive obesity medicine care.
Mochi Health
Mochi Health's FAQ describes a model in which patients have scheduled visits with a licensed clinician and can message their care team between appointments. The platform does not publish the same level of detail about visit frequency or multidisciplinary team composition that Form Health does.
Questions worth asking Mochi Health directly:
How often will I have appointments, and with whom?
Will I see a physician, or primarily a nurse practitioner or other provider?
What is the process if I experience a side effect or need a dose change?
Is a clinician available between scheduled visits?
What to look for in any obesity medicine program
The OMA recommends that a comprehensive obesity medicine program include an initial health and weight history assessment, ongoing lifestyle counseling across nutrition and behavioral health, medication management with regular clinical follow-up, and a long-term management plan. A program that offers medication without these components may not meet the standard of care that obesity medicine guidelines describe.
5Who each platform may be better suited for
These are considerations to help you think through fit, not recommendations. Individual circumstances vary, and a conversation with your own clinician is the most reliable guide. Form Health may be worth exploring if:
You have insurance that covers obesity medicine and want to use it
You want a physician-led team with frequent clinical touchpoints
You have a complex medical history that warrants closer monitoring
You value a documented, multidisciplinary care structure
Mochi Health may be worth exploring if:
You are paying out of pocket and cost is a primary concern
You are looking for a lower-cost entry point to GLP-1 care and are comfortable with a less intensive clinical model
Neither platform may be the right fit if:
You need in-person care, on-site lab draws, or surgical evaluation
Your insurance requires a referral to a specific in-network practice
Your medical history is complex enough to warrant specialist-level in-person oversight
6What to ask before choosing a platform
Before enrolling in any telehealth weight-loss program, consider raising these questions with your own primary care physician or a board-certified obesity medicine specialist: 1. Is GLP-1 medication appropriate for my health profile and weight history? 2. Will my insurance cover this program's visits and the medication itself? 3. What clinical monitoring will I receive, and how often? 4. Who do I contact if I have side effects or a concern between visits? 5. Are the medications prescribed brand-name and FDA-approved, or compounded? If compounded, what is the current regulatory basis for prescribing them? 6. What happens to my care if I can no longer afford the program? 7. How does this telehealth program coordinate with my primary care physician?
7Bottom line
Form Health has a documented, insurance-integrated, physician-led model with a verifiable clinical structure that aligns with OMA guidelines. Mochi Health offers a lower-cost alternative at $99 per month, with licensed clinicians and access to both brand-name and compounded GLP-1 medications, but with less published detail about care intensity and no direct insurance billing. The compounded medication question is the most consequential difference for many patients right now. With the FDA's May 2025 declaration that the semaglutide shortage has ended, the regulatory footing for compounded semaglutide has changed. Any platform still prescribing it should be able to explain the basis for doing so. Patients deserve a clear answer about what they are being prescribed and why, regardless of which platform they choose.
8Frequently asked questions
Are GLP-1 medications covered by insurance through telehealth platforms?
It depends on your plan. Form Health accepts national insurance plans, including Medicare, so visits may be covered. Coverage for the GLP-1 medication itself is a separate question. Many insurers require prior authorization, and approval often depends on documented medical criteria such as BMI and related health conditions. Even with an accepted insurance plan, the medication may not be covered or may require significant cost-sharing. Ask both the platform and your insurer for specifics before assuming coverage. Mochi Health does not bill insurance directly but provides superbills. Whether your insurer will reimburse any portion depends on your plan.
What is the difference between compounded and brand-name GLP-1 medications?
Brand-name GLP-1 medications, such as Ozempic, Wegovy, Mounjaro, and Zepbound, are FDA-approved, meaning they have been reviewed for safety, efficacy, and manufacturing quality. Compounded GLP-1 medications are mixed by compounding pharmacies and have not gone through that review process. The FDA has raised concerns about compounded GLP-1 drugs, including risks related to quality control, dosing errors, and improper storage. Compounded drugs may be legally prescribed in specific circumstances, primarily when an FDA-approved version is unavailable or cannot meet a patient's medical needs. The FDA's May 2025 declaration that the semaglutide shortage has ended affects the legal basis for most compounded semaglutide. Ask any prescriber which type they are recommending, why, and how recent regulatory changes affect your prescription.
How do I know if a telehealth obesity medicine program meets clinical standards?
The OMA provides guidelines for what comprehensive obesity care should include: an initial assessment, ongoing lifestyle counseling, medication management with regular follow-up, and a long-term management plan. Ask about care team credentials, visit frequency, what happens between appointments, and whether the program has a plan for long-term management rather than short-term weight loss only.
Can I use these platforms if I have other health conditions?
Telehealth obesity medicine programs vary in how they handle medical complexity. If you have cardiovascular disease, kidney disease, a history of pancreatitis, or other significant conditions, discuss your full health picture with a clinician before starting any GLP-1 medication. In some cases, in-person care or specialist involvement may be more appropriate than a telehealth-only program.
What does Medicare coverage for obesity medicine actually include?
Medicare covers intensive behavioral therapy for obesity, which includes visits focused on weight loss counseling. Medicare Part D may cover some GLP-1 medications depending on the indication; coverage specifically for weight loss has been limited, though this is an area of ongoing policy change. Form Health's acceptance of Medicare means program visits may be covered, but patients should confirm with Medicare and the platform what is and is not included. Drug coverage under Medicare is plan-specific and subject to formulary and prior authorization requirements.
Is one platform better than the other for weight loss results?
No published comparative outcome data exists between Form Health and Mochi Health. Individual results depend on many factors beyond platform choice, including medication response, adherence, lifestyle factors, and underlying health conditions. The more useful question is which program fits your specific situation, insurance coverage, and clinical needs.
This article is editorial information for general educational purposes. It is not individualized medical advice and should not substitute for consultation with a qualified healthcare provider. Medication decisions, including whether GLP-1 therapy is appropriate for you, should be made with a licensed clinician who knows your full health history. Program details, pricing, and insurance coverage for both platforms may change; verify current information directly with each company before enrolling.
Continue Reading
Why insurers are dropping or changing coverage in 2026
GLP-1 coverage is tightening in 2026, not disappearing. Learn why costs are driving stricter prior authorization and diabetes-vs-weight-loss distinctions, and what questions to ask your doctor, HR team, or insurer to protect your access.
The medical weight-loss provider landscape
Help a patient understand what the medical weight-loss provider landscape looks like and what to evaluate before comparing specific vendors.